Loading clinical trials...
Loading clinical trials...
Feasibility of Continuous Glucose Monitor Use In Hospitalized Youth
This study is assessing the feasibility of a continuous glucose monitor during hospital admissions in youth and young adults with hyperglycemia due to diabetes or other underlying conditions that requires frequent glucose monitoring, through patient/family and nursing staff feedback on their perspectives and usability of the system in the hospital will be assessed through surveys. In addition, retrospective glycemic comparisons between CGM data and POC will be conducted.
Youth and young adult patients admitted to the hospital for any reason, but require glucose monitoring during the hospitalization will be enrolled in this study. Participant diagnosis can include type 1 diabetes, type 2 diabetes, medication-induced diabetes, cystic fibrosis-related diabetes, or other causes of hyperglycemia that it has been determined by the hospital team requires frequent glucose monitoring, with or without insulin management. Enrolled participants will wear a blinded continuous glucose monitor for up to 28 days (2 sensors) or until the end of their hospitalization. In addition, enrolled participants will complete a survey to assess their perspectives on the CGM wear experience and interest in future CGM use during hospitalizations. Nursing staff of the enrolled participant will also be invited to complete a survey regarding their perspectives of CGM use in the hospital setting.
Age
2 - 26 years
Sex
ALL
Healthy Volunteers
No
University of California San Francisco
San Francisco, California, United States
Stanford University
Stanford, California, United States
University of Colorado, Barbara Davis Center
Aurora, Colorado, United States
Start Date
July 15, 2025
Primary Completion Date
February 14, 2027
Completion Date
February 14, 2027
Last Updated
March 3, 2026
120
ESTIMATED participants
Freestyle Libre 3 Continuous Glucose Monitor
DEVICE
Lead Sponsor
University of Colorado, Denver
Collaborators
NCT06561126
NCT07125885
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions